EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

Genetically modified pigs with α1,3-galactosyltransferase knockout and beyond: a comprehensive review of xenotransplantation strategies

Ewelina Stelcer, Anna Wozniak, Dorota Magner, Joanna Zeyland

Frontiers in Immunology · 2025

DOI: 10.3389/fimmu.2025.1663246 ↗

At a glance

Übersichtsarbeit in Frontiers in Immunology, 2025. Written by Ewelina Stelcer and 3 co-authors. Institution: Department of Biochemistry and Biotechnology, Poznan University of Life Sciences, Poznan, Poland. Major MEDLINE topics: Transplantation, Heterologous, Galactosyltransferases, Animals, Genetically Modified, Graft Rejection. Cited 4 times so far (Crossref); 97 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Xenotransplantation holds promise to eliminate the shortage of organs intended for humans in need. Pigs constitute the most suitable organ xenograft donor due to the fact that their organ anatomy physiological metabolism and immune system resemble those of humans. However, swine organs rapidly cause hyperacute rejection (HAR) and acute humoral xenograft rejection (AHXR) after transplantation. HAR and AHXR are caused by the presence of xenoreactive natural immunoglobulins directed toward a galactose alpha1-3-galactose (alpha-Gal) epitope on porcine vascular endothelium. In order to suppress both types of rejection, pigs with alpha1,3-galactosyltransferase gene knockout (GT-KO) and other genetic modifications (like simultaneous expression of the human complementary regulatory proteins) are intensively investigated. This review highlights the usefulness of GT-KO pig – derived organs such as kidney, heart, corneal, and lung in xenotransplantation. To obtain transgenic pigs researchers can use several techniques based on pronuclear and cytoplasmic microinjection, somatic cell nuclear transfer (SCNT), viral transduction of DNA and DNA transposable element -based technology, site specific nucleases and modifications of the CRISPR/Cas bacterial immune system. Some additional strategies like targeted immunosuppression or tolerance induction of B and T cells will be essential for sustained survival of xenografts. Although xenotransplantation with the use of pigs is a very rapidly evolving field, more research is needed to create perfectly compatible with the human immune system organs.

Subjects

MeSH terms (MEDLINE)

Transplantation, HeterologousGalactosyltransferasesAnimals, Genetically ModifiedGraft RejectionAnimalsSwineGene Knockout TechniquesHumansHeterografts

Author keywords

alpa-Gal epitopealpha-1,3-galactosyltransferaseanti-Gal specific antibodieshyperacute rejection (HAR)xenotransplantation

Substances

Galactosyltransferasesalpha-1,3-galactosyltransferase 1, porcine

Authors and institutions

  • Department of Biochemistry and Biotechnology, Poznan University of Life Sciences, Poznan, Poland.

Cite

APA

Stelcer, E., Wozniak, A., Magner, D., & Zeyland, J. (2025). Genetically modified pigs with α1,3-galactosyltransferase knockout and beyond: a comprehensive review of xenotransplantation strategies. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1663246

Vancouver

Stelcer E, Wozniak A, Magner D, Zeyland J. Genetically modified pigs with α1,3-galactosyltransferase knockout and beyond: a comprehensive review of xenotransplantation strategies. Frontiers in Immunology. 2025. doi:10.3389/fimmu.2025.1663246

BibTeX
@article{Stelcer2025,
  author = {Stelcer, Ewelina and Wozniak, Anna and Magner, Dorota and Zeyland, Joanna},
  title = {Genetically modified pigs with α1,3-galactosyltransferase knockout and beyond: a comprehensive review of xenotransplantation strategies},
  journal = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1663246}
}
Start for free →